Jag Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-5,124
| Closed | -$131K | – | 157 |
|
|
2025
Q3 | $131K | Buy |
+5,124
| New | +$126K | 0.01% | 134 |
|
|
2024
Q4 | – | Sell |
-6,346
| Closed | -$184K | – | 141 |
|
|
2024
Q3 | $184K | Hold |
6,346
| – | – | 0.02% | 127 |
|
|
2024
Q2 | $178K | Sell |
6,346
-5,000
| -44% | -$138K | 0.02% | 127 |
|
|
2024
Q1 | $315K | Buy |
11,346
+206
| +2% | +$5.72K | 0.04% | 108 |
|
|
2023
Q4 | $321K | Buy |
11,140
+203
| +2% | +$6.14K | 0.05% | 100 |
|
|
2023
Q3 | $363K | Buy |
10,937
+1
| +0% | +$35 | 0.04% | 137 |
|
|
2023
Q2 | $401K | Sell |
10,936
-100
| -0.9% | -$3.89K | 0.05% | 133 |
|
|
2023
Q1 | $450K | Buy |
11,036
+100
| +0.9% | +$4.32K | 0.06% | 131 |
|
|
2022
Q4 | $560K | Sell |
10,936
-761
| -7% | -$36.5K | 0.08% | 120 |
|
|
2022
Q3 | $512K | Buy |
11,697
+500
| +4% | +$24.3K | 0.07% | 127 |
|
|
2022
Q2 | $587K | Buy |
+11,197
| New | +$571K | 0.07% | 128 |
|
|
2022
Q1 | – | Sell |
-11,897
| Closed | -$703K | – | 250 |
|
|
2021
Q4 | $703K | Sell |
11,897
-6,010
| -34% | -$298K | 0.05% | 130 |
|
|
2021
Q3 | $770K | Buy |
17,907
+4,805
| +37% | +$213K | 0.06% | 130 |
|
|
2021
Q2 | $513K | Buy |
13,102
+68
| +0.5% | +$2.64K | 0.04% | 159 |
|
|
2021
Q1 | $472K | Sell |
13,034
-1,398
| -10% | -$49.6K | 0.04% | 157 |
|
|
2020
Q4 | $513K | Buy |
14,432
+1,814
| +14% | +$66.5K | 0.05% | 136 |
|
|
2020
Q3 | $439K | Hold |
12,618
| – | – | 0.05% | 130 |
|
|
2020
Q2 | $391K | Hold |
12,618
| – | – | 0.05% | 130 |
|
|
2020
Q1 | $391K | Sell |
12,618
-422
| -3% | -$14.4K | 0.06% | 127 |
|
|
2019
Q4 | $485K | Buy |
13,040
+1,224
| +10% | +$43.6K | 0.06% | 149 |
|
|
2019
Q3 | $403K | Sell |
11,816
-8
| -0.1% | -$291 | 0.05% | 154 |
|
|
2019
Q2 | $486K | Buy |
11,824
+6,081
| +106% | +$241K | 0.05% | 151 |
|
|
2019
Q1 | $231K | Sell |
5,743
-110
| -2% | -$4.41K | 0.04% | 95 |
|
|
2018
Q4 | $242K | Buy |
5,853
+3
| +0.1% | +$125 | 0.05% | 92 |
|
|
2018
Q3 | $245K | Buy |
5,850
+2
| +0% | +$77 | 0.04% | 90 |
|
|
2018
Q2 | $201K | Buy |
+5,848
| New | +$200K | 0.03% | 98 |
|
|
2018
Q1 | – | Sell |
-5,842
| Closed | -$201K | – | 108 |
|
|
2017
Q4 | $201K | Buy |
+5,842
| New | +$199K | 0.04% | 94 |
|
|
2016
Q3 | – | Sell |
-6,036
| Closed | -$202K | – | 120 |
|
|
2016
Q2 | $202K | Buy |
+6,036
| New | +$193K | 0.04% | 110 |
|
|
2013
Q3 | – | Sell |
-10,073
| Closed | -$268K | – | 92 |
|
|
2013
Q2 | $268K | Buy |
+10,073
| New | +$278K | 0.07% | 90 |
|
Other funds holding PFE
Jag Capital Management's PFE Position: Q4 2025 in Review
Jag Capital Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 5,124 shares — an estimated $131K sold.
Jag Capital Management first reported a position in PFE in Q2 2013 and held it in 29 quarters. The position peaked at $770K in Q3 2021. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Jag Capital Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Jag Capital Management sold 5,124 Pfizer shares in Q4 2025, an estimated $131K.
- Jag Capital Management first reported a position in Pfizer in Q2 2013 and held it in 29 quarters.
- Jag Capital Management's Pfizer position peaked at $770K in Q3 2021.
- 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Jag Capital Management's 13F filing for Q4 2025, filed 6 Feb 2026.